Pharma & Healthcare
Global Naftopidil Market Research Report 2025
- Mar 11, 25
- ID: 30897
- Pages: 90
- Figures: 91
- Views: 14
The global market for Naftopidil was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
North American market for Naftopidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Naftopidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Naftopidil include Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, Mylan Laboratories, RA Chem Pharma, Syn-Tech Chem & Pharm, Procos, Sagami Chemical Industry, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Naftopidil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naftopidil.
The Naftopidil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Naftopidil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naftopidil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sinopharm Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Aurobindo Pharma
Erregierre
Jeil Pharmaceutical
Mylan Laboratories
RA Chem Pharma
Syn-Tech Chem & Pharm
Procos
Sagami Chemical Industry
Daito Pharmaceutical
Iwaki Seiyaku
Hainan Simcere Pharmaceutical
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naftopidil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naftopidil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
North American market for Naftopidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Naftopidil is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Naftopidil include Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, Mylan Laboratories, RA Chem Pharma, Syn-Tech Chem & Pharm, Procos, Sagami Chemical Industry, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Naftopidil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naftopidil.
The Naftopidil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Naftopidil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naftopidil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sinopharm Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Aurobindo Pharma
Erregierre
Jeil Pharmaceutical
Mylan Laboratories
RA Chem Pharma
Syn-Tech Chem & Pharm
Procos
Sagami Chemical Industry
Daito Pharmaceutical
Iwaki Seiyaku
Hainan Simcere Pharmaceutical
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naftopidil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naftopidil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Naftopidil Market Overview
1.1 Product Definition
1.2 Naftopidil by Type
1.2.1 Global Naftopidil Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Naftopidil by Application
1.3.1 Global Naftopidil Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Naftopidil Market Size Estimates and Forecasts
1.4.1 Global Naftopidil Revenue 2020-2031
1.4.2 Global Naftopidil Sales 2020-2031
1.4.3 Global Naftopidil Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Naftopidil Market Competition by Manufacturers
2.1 Global Naftopidil Sales Market Share by Manufacturers (2020-2025)
2.2 Global Naftopidil Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Naftopidil Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Naftopidil, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Naftopidil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naftopidil, Product Type & Application
2.7 Global Key Manufacturers of Naftopidil, Date of Enter into This Industry
2.8 Global Naftopidil Market Competitive Situation and Trends
2.8.1 Global Naftopidil Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Naftopidil Players Market Share by Revenue
2.8.3 Global Naftopidil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Naftopidil Market Scenario by Region
3.1 Global Naftopidil Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Naftopidil Sales by Region: 2020-2031
3.2.1 Global Naftopidil Sales by Region: 2020-2025
3.2.2 Global Naftopidil Sales by Region: 2026-2031
3.3 Global Naftopidil Revenue by Region: 2020-2031
3.3.1 Global Naftopidil Revenue by Region: 2020-2025
3.3.2 Global Naftopidil Revenue by Region: 2026-2031
3.4 North America Naftopidil Market Facts & Figures by Country
3.4.1 North America Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Naftopidil Sales by Country (2020-2031)
3.4.3 North America Naftopidil Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Naftopidil Market Facts & Figures by Country
3.5.1 Europe Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Naftopidil Sales by Country (2020-2031)
3.5.3 Europe Naftopidil Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naftopidil Market Facts & Figures by Region
3.6.1 Asia Pacific Naftopidil Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Naftopidil Sales by Region (2020-2031)
3.6.3 Asia Pacific Naftopidil Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Naftopidil Market Facts & Figures by Country
3.7.1 Latin America Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Naftopidil Sales by Country (2020-2031)
3.7.3 Latin America Naftopidil Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naftopidil Market Facts & Figures by Country
3.8.1 Middle East and Africa Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Naftopidil Sales by Country (2020-2031)
3.8.3 Middle East and Africa Naftopidil Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naftopidil Sales by Type (2020-2031)
4.1.1 Global Naftopidil Sales by Type (2020-2025)
4.1.2 Global Naftopidil Sales by Type (2026-2031)
4.1.3 Global Naftopidil Sales Market Share by Type (2020-2031)
4.2 Global Naftopidil Revenue by Type (2020-2031)
4.2.1 Global Naftopidil Revenue by Type (2020-2025)
4.2.2 Global Naftopidil Revenue by Type (2026-2031)
4.2.3 Global Naftopidil Revenue Market Share by Type (2020-2031)
4.3 Global Naftopidil Price by Type (2020-2031)
5 Segment by Application
5.1 Global Naftopidil Sales by Application (2020-2031)
5.1.1 Global Naftopidil Sales by Application (2020-2025)
5.1.2 Global Naftopidil Sales by Application (2026-2031)
5.1.3 Global Naftopidil Sales Market Share by Application (2020-2031)
5.2 Global Naftopidil Revenue by Application (2020-2031)
5.2.1 Global Naftopidil Revenue by Application (2020-2025)
5.2.2 Global Naftopidil Revenue by Application (2026-2031)
5.2.3 Global Naftopidil Revenue Market Share by Application (2020-2031)
5.3 Global Naftopidil Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sinopharm Weiqida Pharmaceutical
6.1.1 Sinopharm Weiqida Pharmaceutical Company Information
6.1.2 Sinopharm Weiqida Pharmaceutical Description and Business Overview
6.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolio
6.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Naftopidil Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Erregierre
6.4.1 Erregierre Company Information
6.4.2 Erregierre Description and Business Overview
6.4.3 Erregierre Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Erregierre Naftopidil Product Portfolio
6.4.5 Erregierre Recent Developments/Updates
6.5 Jeil Pharmaceutical
6.5.1 Jeil Pharmaceutical Company Information
6.5.2 Jeil Pharmaceutical Description and Business Overview
6.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jeil Pharmaceutical Naftopidil Product Portfolio
6.5.5 Jeil Pharmaceutical Recent Developments/Updates
6.6 Mylan Laboratories
6.6.1 Mylan Laboratories Company Information
6.6.2 Mylan Laboratories Description and Business Overview
6.6.3 Mylan Laboratories Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Laboratories Naftopidil Product Portfolio
6.6.5 Mylan Laboratories Recent Developments/Updates
6.7 RA Chem Pharma
6.7.1 RA Chem Pharma Company Information
6.7.2 RA Chem Pharma Description and Business Overview
6.7.3 RA Chem Pharma Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.7.4 RA Chem Pharma Naftopidil Product Portfolio
6.7.5 RA Chem Pharma Recent Developments/Updates
6.8 Syn-Tech Chem & Pharm
6.8.1 Syn-Tech Chem & Pharm Company Information
6.8.2 Syn-Tech Chem & Pharm Description and Business Overview
6.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Syn-Tech Chem & Pharm Naftopidil Product Portfolio
6.8.5 Syn-Tech Chem & Pharm Recent Developments/Updates
6.9 Procos
6.9.1 Procos Company Information
6.9.2 Procos Description and Business Overview
6.9.3 Procos Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Procos Naftopidil Product Portfolio
6.9.5 Procos Recent Developments/Updates
6.10 Sagami Chemical Industry
6.10.1 Sagami Chemical Industry Company Information
6.10.2 Sagami Chemical Industry Description and Business Overview
6.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sagami Chemical Industry Naftopidil Product Portfolio
6.10.5 Sagami Chemical Industry Recent Developments/Updates
6.11 Daito Pharmaceutical
6.11.1 Daito Pharmaceutical Company Information
6.11.2 Daito Pharmaceutical Description and Business Overview
6.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Daito Pharmaceutical Naftopidil Product Portfolio
6.11.5 Daito Pharmaceutical Recent Developments/Updates
6.12 Iwaki Seiyaku
6.12.1 Iwaki Seiyaku Company Information
6.12.2 Iwaki Seiyaku Description and Business Overview
6.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Iwaki Seiyaku Naftopidil Product Portfolio
6.12.5 Iwaki Seiyaku Recent Developments/Updates
6.13 Hainan Simcere Pharmaceutical
6.13.1 Hainan Simcere Pharmaceutical Company Information
6.13.2 Hainan Simcere Pharmaceutical Description and Business Overview
6.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hainan Simcere Pharmaceutical Naftopidil Product Portfolio
6.13.5 Hainan Simcere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naftopidil Industry Chain Analysis
7.2 Naftopidil Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naftopidil Production Mode & Process Analysis
7.4 Naftopidil Sales and Marketing
7.4.1 Naftopidil Sales Channels
7.4.2 Naftopidil Distributors
7.5 Naftopidil Customer Analysis
8 Naftopidil Market Dynamics
8.1 Naftopidil Industry Trends
8.2 Naftopidil Market Drivers
8.3 Naftopidil Market Challenges
8.4 Naftopidil Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Naftopidil by Type
1.2.1 Global Naftopidil Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Naftopidil by Application
1.3.1 Global Naftopidil Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Naftopidil Market Size Estimates and Forecasts
1.4.1 Global Naftopidil Revenue 2020-2031
1.4.2 Global Naftopidil Sales 2020-2031
1.4.3 Global Naftopidil Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Naftopidil Market Competition by Manufacturers
2.1 Global Naftopidil Sales Market Share by Manufacturers (2020-2025)
2.2 Global Naftopidil Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Naftopidil Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Naftopidil, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Naftopidil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naftopidil, Product Type & Application
2.7 Global Key Manufacturers of Naftopidil, Date of Enter into This Industry
2.8 Global Naftopidil Market Competitive Situation and Trends
2.8.1 Global Naftopidil Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Naftopidil Players Market Share by Revenue
2.8.3 Global Naftopidil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Naftopidil Market Scenario by Region
3.1 Global Naftopidil Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Naftopidil Sales by Region: 2020-2031
3.2.1 Global Naftopidil Sales by Region: 2020-2025
3.2.2 Global Naftopidil Sales by Region: 2026-2031
3.3 Global Naftopidil Revenue by Region: 2020-2031
3.3.1 Global Naftopidil Revenue by Region: 2020-2025
3.3.2 Global Naftopidil Revenue by Region: 2026-2031
3.4 North America Naftopidil Market Facts & Figures by Country
3.4.1 North America Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Naftopidil Sales by Country (2020-2031)
3.4.3 North America Naftopidil Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Naftopidil Market Facts & Figures by Country
3.5.1 Europe Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Naftopidil Sales by Country (2020-2031)
3.5.3 Europe Naftopidil Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naftopidil Market Facts & Figures by Region
3.6.1 Asia Pacific Naftopidil Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Naftopidil Sales by Region (2020-2031)
3.6.3 Asia Pacific Naftopidil Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Naftopidil Market Facts & Figures by Country
3.7.1 Latin America Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Naftopidil Sales by Country (2020-2031)
3.7.3 Latin America Naftopidil Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naftopidil Market Facts & Figures by Country
3.8.1 Middle East and Africa Naftopidil Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Naftopidil Sales by Country (2020-2031)
3.8.3 Middle East and Africa Naftopidil Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naftopidil Sales by Type (2020-2031)
4.1.1 Global Naftopidil Sales by Type (2020-2025)
4.1.2 Global Naftopidil Sales by Type (2026-2031)
4.1.3 Global Naftopidil Sales Market Share by Type (2020-2031)
4.2 Global Naftopidil Revenue by Type (2020-2031)
4.2.1 Global Naftopidil Revenue by Type (2020-2025)
4.2.2 Global Naftopidil Revenue by Type (2026-2031)
4.2.3 Global Naftopidil Revenue Market Share by Type (2020-2031)
4.3 Global Naftopidil Price by Type (2020-2031)
5 Segment by Application
5.1 Global Naftopidil Sales by Application (2020-2031)
5.1.1 Global Naftopidil Sales by Application (2020-2025)
5.1.2 Global Naftopidil Sales by Application (2026-2031)
5.1.3 Global Naftopidil Sales Market Share by Application (2020-2031)
5.2 Global Naftopidil Revenue by Application (2020-2031)
5.2.1 Global Naftopidil Revenue by Application (2020-2025)
5.2.2 Global Naftopidil Revenue by Application (2026-2031)
5.2.3 Global Naftopidil Revenue Market Share by Application (2020-2031)
5.3 Global Naftopidil Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sinopharm Weiqida Pharmaceutical
6.1.1 Sinopharm Weiqida Pharmaceutical Company Information
6.1.2 Sinopharm Weiqida Pharmaceutical Description and Business Overview
6.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolio
6.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Company Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Naftopidil Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Erregierre
6.4.1 Erregierre Company Information
6.4.2 Erregierre Description and Business Overview
6.4.3 Erregierre Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Erregierre Naftopidil Product Portfolio
6.4.5 Erregierre Recent Developments/Updates
6.5 Jeil Pharmaceutical
6.5.1 Jeil Pharmaceutical Company Information
6.5.2 Jeil Pharmaceutical Description and Business Overview
6.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jeil Pharmaceutical Naftopidil Product Portfolio
6.5.5 Jeil Pharmaceutical Recent Developments/Updates
6.6 Mylan Laboratories
6.6.1 Mylan Laboratories Company Information
6.6.2 Mylan Laboratories Description and Business Overview
6.6.3 Mylan Laboratories Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Laboratories Naftopidil Product Portfolio
6.6.5 Mylan Laboratories Recent Developments/Updates
6.7 RA Chem Pharma
6.7.1 RA Chem Pharma Company Information
6.7.2 RA Chem Pharma Description and Business Overview
6.7.3 RA Chem Pharma Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.7.4 RA Chem Pharma Naftopidil Product Portfolio
6.7.5 RA Chem Pharma Recent Developments/Updates
6.8 Syn-Tech Chem & Pharm
6.8.1 Syn-Tech Chem & Pharm Company Information
6.8.2 Syn-Tech Chem & Pharm Description and Business Overview
6.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Syn-Tech Chem & Pharm Naftopidil Product Portfolio
6.8.5 Syn-Tech Chem & Pharm Recent Developments/Updates
6.9 Procos
6.9.1 Procos Company Information
6.9.2 Procos Description and Business Overview
6.9.3 Procos Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Procos Naftopidil Product Portfolio
6.9.5 Procos Recent Developments/Updates
6.10 Sagami Chemical Industry
6.10.1 Sagami Chemical Industry Company Information
6.10.2 Sagami Chemical Industry Description and Business Overview
6.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sagami Chemical Industry Naftopidil Product Portfolio
6.10.5 Sagami Chemical Industry Recent Developments/Updates
6.11 Daito Pharmaceutical
6.11.1 Daito Pharmaceutical Company Information
6.11.2 Daito Pharmaceutical Description and Business Overview
6.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Daito Pharmaceutical Naftopidil Product Portfolio
6.11.5 Daito Pharmaceutical Recent Developments/Updates
6.12 Iwaki Seiyaku
6.12.1 Iwaki Seiyaku Company Information
6.12.2 Iwaki Seiyaku Description and Business Overview
6.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Iwaki Seiyaku Naftopidil Product Portfolio
6.12.5 Iwaki Seiyaku Recent Developments/Updates
6.13 Hainan Simcere Pharmaceutical
6.13.1 Hainan Simcere Pharmaceutical Company Information
6.13.2 Hainan Simcere Pharmaceutical Description and Business Overview
6.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hainan Simcere Pharmaceutical Naftopidil Product Portfolio
6.13.5 Hainan Simcere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naftopidil Industry Chain Analysis
7.2 Naftopidil Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naftopidil Production Mode & Process Analysis
7.4 Naftopidil Sales and Marketing
7.4.1 Naftopidil Sales Channels
7.4.2 Naftopidil Distributors
7.5 Naftopidil Customer Analysis
8 Naftopidil Market Dynamics
8.1 Naftopidil Industry Trends
8.2 Naftopidil Market Drivers
8.3 Naftopidil Market Challenges
8.4 Naftopidil Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Naftopidil Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Naftopidil Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Naftopidil Market Competitive Situation by Manufacturers in 2024
Table 4. Global Naftopidil Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Naftopidil Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Naftopidil Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Naftopidil Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Naftopidil Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Naftopidil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Naftopidil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Naftopidil, Product Type & Application
Table 12. Global Key Manufacturers of Naftopidil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Naftopidil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naftopidil as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Naftopidil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Naftopidil Sales by Region (2020-2025) & (K Units)
Table 18. Global Naftopidil Sales Market Share by Region (2020-2025)
Table 19. Global Naftopidil Sales by Region (2026-2031) & (K Units)
Table 20. Global Naftopidil Sales Market Share by Region (2026-2031)
Table 21. Global Naftopidil Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Naftopidil Revenue Market Share by Region (2020-2025)
Table 23. Global Naftopidil Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Naftopidil Revenue Market Share by Region (2026-2031)
Table 25. North America Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Naftopidil Sales by Country (2020-2025) & (K Units)
Table 27. North America Naftopidil Sales by Country (2026-2031) & (K Units)
Table 28. North America Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Naftopidil Sales by Country (2020-2025) & (K Units)
Table 32. Europe Naftopidil Sales by Country (2026-2031) & (K Units)
Table 33. Europe Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Naftopidil Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Naftopidil Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Naftopidil Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Naftopidil Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Naftopidil Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Naftopidil Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Naftopidil Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Naftopidil Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Naftopidil Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Naftopidil Sales (K Units) by Type (2020-2025)
Table 51. Global Naftopidil Sales (K Units) by Type (2026-2031)
Table 52. Global Naftopidil Sales Market Share by Type (2020-2025)
Table 53. Global Naftopidil Sales Market Share by Type (2026-2031)
Table 54. Global Naftopidil Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Naftopidil Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Naftopidil Revenue Market Share by Type (2020-2025)
Table 57. Global Naftopidil Revenue Market Share by Type (2026-2031)
Table 58. Global Naftopidil Price (US$/Unit) by Type (2020-2025)
Table 59. Global Naftopidil Price (US$/Unit) by Type (2026-2031)
Table 60. Global Naftopidil Sales (K Units) by Application (2020-2025)
Table 61. Global Naftopidil Sales (K Units) by Application (2026-2031)
Table 62. Global Naftopidil Sales Market Share by Application (2020-2025)
Table 63. Global Naftopidil Sales Market Share by Application (2026-2031)
Table 64. Global Naftopidil Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Naftopidil Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Naftopidil Revenue Market Share by Application (2020-2025)
Table 67. Global Naftopidil Revenue Market Share by Application (2026-2031)
Table 68. Global Naftopidil Price (US$/Unit) by Application (2020-2025)
Table 69. Global Naftopidil Price (US$/Unit) by Application (2026-2031)
Table 70. Sinopharm Weiqida Pharmaceutical Company Information
Table 71. Sinopharm Weiqida Pharmaceutical Description and Business Overview
Table 72. Sinopharm Weiqida Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sinopharm Weiqida Pharmaceutical Naftopidil Product
Table 74. Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
Table 75. Shanghai Shyndec Pharmaceutical Company Information
Table 76. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 77. Shanghai Shyndec Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Shanghai Shyndec Pharmaceutical Naftopidil Product
Table 79. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 80. Aurobindo Pharma Company Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma Naftopidil Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Erregierre Company Information
Table 86. Erregierre Description and Business Overview
Table 87. Erregierre Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Erregierre Naftopidil Product
Table 89. Erregierre Recent Developments/Updates
Table 90. Jeil Pharmaceutical Company Information
Table 91. Jeil Pharmaceutical Description and Business Overview
Table 92. Jeil Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Jeil Pharmaceutical Naftopidil Product
Table 94. Jeil Pharmaceutical Recent Developments/Updates
Table 95. Mylan Laboratories Company Information
Table 96. Mylan Laboratories Description and Business Overview
Table 97. Mylan Laboratories Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mylan Laboratories Naftopidil Product
Table 99. Mylan Laboratories Recent Developments/Updates
Table 100. RA Chem Pharma Company Information
Table 101. RA Chem Pharma Description and Business Overview
Table 102. RA Chem Pharma Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. RA Chem Pharma Naftopidil Product
Table 104. RA Chem Pharma Recent Developments/Updates
Table 105. Syn-Tech Chem & Pharm Company Information
Table 106. Syn-Tech Chem & Pharm Description and Business Overview
Table 107. Syn-Tech Chem & Pharm Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Syn-Tech Chem & Pharm Naftopidil Product
Table 109. Syn-Tech Chem & Pharm Recent Developments/Updates
Table 110. Procos Company Information
Table 111. Procos Description and Business Overview
Table 112. Procos Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Procos Naftopidil Product
Table 114. Procos Recent Developments/Updates
Table 115. Sagami Chemical Industry Company Information
Table 116. Sagami Chemical Industry Description and Business Overview
Table 117. Sagami Chemical Industry Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sagami Chemical Industry Naftopidil Product
Table 119. Sagami Chemical Industry Recent Developments/Updates
Table 120. Daito Pharmaceutical Company Information
Table 121. Daito Pharmaceutical Description and Business Overview
Table 122. Daito Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Daito Pharmaceutical Naftopidil Product
Table 124. Daito Pharmaceutical Recent Developments/Updates
Table 125. Iwaki Seiyaku Company Information
Table 126. Iwaki Seiyaku Description and Business Overview
Table 127. Iwaki Seiyaku Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Iwaki Seiyaku Naftopidil Product
Table 129. Iwaki Seiyaku Recent Developments/Updates
Table 130. Hainan Simcere Pharmaceutical Company Information
Table 131. Hainan Simcere Pharmaceutical Description and Business Overview
Table 132. Hainan Simcere Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hainan Simcere Pharmaceutical Naftopidil Product
Table 134. Hainan Simcere Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Naftopidil Distributors List
Table 138. Naftopidil Customers List
Table 139. Naftopidil Market Trends
Table 140. Naftopidil Market Drivers
Table 141. Naftopidil Market Challenges
Table 142. Naftopidil Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Naftopidil
Figure 2. Global Naftopidil Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Naftopidil Market Share by Type: 2024 & 2031
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Naftopidil Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Naftopidil Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Naftopidil Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Naftopidil Market Size (2020-2031) & (US$ Million)
Figure 12. Global Naftopidil Sales (2020-2031) & (K Units)
Figure 13. Global Naftopidil Average Price (US$/Unit) & (2020-2031)
Figure 14. Naftopidil Report Years Considered
Figure 15. Naftopidil Sales Share by Manufacturers in 2024
Figure 16. Global Naftopidil Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Naftopidil Players: Market Share by Revenue in Naftopidil in 2024
Figure 18. Naftopidil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Naftopidil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Naftopidil Sales Market Share by Country (2020-2031)
Figure 21. North America Naftopidil Revenue Market Share by Country (2020-2031)
Figure 22. United States Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Naftopidil Sales Market Share by Country (2020-2031)
Figure 25. Europe Naftopidil Revenue Market Share by Country (2020-2031)
Figure 26. Germany Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Naftopidil Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Naftopidil Revenue Market Share by Region (2020-2031)
Figure 33. China Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Naftopidil Sales Market Share by Country (2020-2031)
Figure 43. Latin America Naftopidil Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Naftopidil Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Naftopidil Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Naftopidil by Type (2020-2031)
Figure 53. Global Revenue Market Share of Naftopidil by Type (2020-2031)
Figure 54. Global Naftopidil Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Naftopidil by Application (2020-2031)
Figure 56. Global Revenue Market Share of Naftopidil by Application (2020-2031)
Figure 57. Global Naftopidil Price (US$/Unit) by Application (2020-2031)
Figure 58. Naftopidil Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Naftopidil Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Naftopidil Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Naftopidil Market Competitive Situation by Manufacturers in 2024
Table 4. Global Naftopidil Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Naftopidil Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Naftopidil Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Naftopidil Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Naftopidil Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Naftopidil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Naftopidil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Naftopidil, Product Type & Application
Table 12. Global Key Manufacturers of Naftopidil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Naftopidil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naftopidil as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Naftopidil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Naftopidil Sales by Region (2020-2025) & (K Units)
Table 18. Global Naftopidil Sales Market Share by Region (2020-2025)
Table 19. Global Naftopidil Sales by Region (2026-2031) & (K Units)
Table 20. Global Naftopidil Sales Market Share by Region (2026-2031)
Table 21. Global Naftopidil Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Naftopidil Revenue Market Share by Region (2020-2025)
Table 23. Global Naftopidil Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Naftopidil Revenue Market Share by Region (2026-2031)
Table 25. North America Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Naftopidil Sales by Country (2020-2025) & (K Units)
Table 27. North America Naftopidil Sales by Country (2026-2031) & (K Units)
Table 28. North America Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Naftopidil Sales by Country (2020-2025) & (K Units)
Table 32. Europe Naftopidil Sales by Country (2026-2031) & (K Units)
Table 33. Europe Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Naftopidil Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Naftopidil Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Naftopidil Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Naftopidil Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Naftopidil Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Naftopidil Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Naftopidil Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Naftopidil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Naftopidil Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Naftopidil Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Naftopidil Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Naftopidil Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Naftopidil Sales (K Units) by Type (2020-2025)
Table 51. Global Naftopidil Sales (K Units) by Type (2026-2031)
Table 52. Global Naftopidil Sales Market Share by Type (2020-2025)
Table 53. Global Naftopidil Sales Market Share by Type (2026-2031)
Table 54. Global Naftopidil Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Naftopidil Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Naftopidil Revenue Market Share by Type (2020-2025)
Table 57. Global Naftopidil Revenue Market Share by Type (2026-2031)
Table 58. Global Naftopidil Price (US$/Unit) by Type (2020-2025)
Table 59. Global Naftopidil Price (US$/Unit) by Type (2026-2031)
Table 60. Global Naftopidil Sales (K Units) by Application (2020-2025)
Table 61. Global Naftopidil Sales (K Units) by Application (2026-2031)
Table 62. Global Naftopidil Sales Market Share by Application (2020-2025)
Table 63. Global Naftopidil Sales Market Share by Application (2026-2031)
Table 64. Global Naftopidil Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Naftopidil Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Naftopidil Revenue Market Share by Application (2020-2025)
Table 67. Global Naftopidil Revenue Market Share by Application (2026-2031)
Table 68. Global Naftopidil Price (US$/Unit) by Application (2020-2025)
Table 69. Global Naftopidil Price (US$/Unit) by Application (2026-2031)
Table 70. Sinopharm Weiqida Pharmaceutical Company Information
Table 71. Sinopharm Weiqida Pharmaceutical Description and Business Overview
Table 72. Sinopharm Weiqida Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sinopharm Weiqida Pharmaceutical Naftopidil Product
Table 74. Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
Table 75. Shanghai Shyndec Pharmaceutical Company Information
Table 76. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 77. Shanghai Shyndec Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Shanghai Shyndec Pharmaceutical Naftopidil Product
Table 79. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 80. Aurobindo Pharma Company Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma Naftopidil Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Erregierre Company Information
Table 86. Erregierre Description and Business Overview
Table 87. Erregierre Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Erregierre Naftopidil Product
Table 89. Erregierre Recent Developments/Updates
Table 90. Jeil Pharmaceutical Company Information
Table 91. Jeil Pharmaceutical Description and Business Overview
Table 92. Jeil Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Jeil Pharmaceutical Naftopidil Product
Table 94. Jeil Pharmaceutical Recent Developments/Updates
Table 95. Mylan Laboratories Company Information
Table 96. Mylan Laboratories Description and Business Overview
Table 97. Mylan Laboratories Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mylan Laboratories Naftopidil Product
Table 99. Mylan Laboratories Recent Developments/Updates
Table 100. RA Chem Pharma Company Information
Table 101. RA Chem Pharma Description and Business Overview
Table 102. RA Chem Pharma Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. RA Chem Pharma Naftopidil Product
Table 104. RA Chem Pharma Recent Developments/Updates
Table 105. Syn-Tech Chem & Pharm Company Information
Table 106. Syn-Tech Chem & Pharm Description and Business Overview
Table 107. Syn-Tech Chem & Pharm Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Syn-Tech Chem & Pharm Naftopidil Product
Table 109. Syn-Tech Chem & Pharm Recent Developments/Updates
Table 110. Procos Company Information
Table 111. Procos Description and Business Overview
Table 112. Procos Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Procos Naftopidil Product
Table 114. Procos Recent Developments/Updates
Table 115. Sagami Chemical Industry Company Information
Table 116. Sagami Chemical Industry Description and Business Overview
Table 117. Sagami Chemical Industry Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sagami Chemical Industry Naftopidil Product
Table 119. Sagami Chemical Industry Recent Developments/Updates
Table 120. Daito Pharmaceutical Company Information
Table 121. Daito Pharmaceutical Description and Business Overview
Table 122. Daito Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Daito Pharmaceutical Naftopidil Product
Table 124. Daito Pharmaceutical Recent Developments/Updates
Table 125. Iwaki Seiyaku Company Information
Table 126. Iwaki Seiyaku Description and Business Overview
Table 127. Iwaki Seiyaku Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Iwaki Seiyaku Naftopidil Product
Table 129. Iwaki Seiyaku Recent Developments/Updates
Table 130. Hainan Simcere Pharmaceutical Company Information
Table 131. Hainan Simcere Pharmaceutical Description and Business Overview
Table 132. Hainan Simcere Pharmaceutical Naftopidil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hainan Simcere Pharmaceutical Naftopidil Product
Table 134. Hainan Simcere Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Naftopidil Distributors List
Table 138. Naftopidil Customers List
Table 139. Naftopidil Market Trends
Table 140. Naftopidil Market Drivers
Table 141. Naftopidil Market Challenges
Table 142. Naftopidil Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Naftopidil
Figure 2. Global Naftopidil Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Naftopidil Market Share by Type: 2024 & 2031
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Naftopidil Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Naftopidil Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Naftopidil Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Naftopidil Market Size (2020-2031) & (US$ Million)
Figure 12. Global Naftopidil Sales (2020-2031) & (K Units)
Figure 13. Global Naftopidil Average Price (US$/Unit) & (2020-2031)
Figure 14. Naftopidil Report Years Considered
Figure 15. Naftopidil Sales Share by Manufacturers in 2024
Figure 16. Global Naftopidil Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Naftopidil Players: Market Share by Revenue in Naftopidil in 2024
Figure 18. Naftopidil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Naftopidil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Naftopidil Sales Market Share by Country (2020-2031)
Figure 21. North America Naftopidil Revenue Market Share by Country (2020-2031)
Figure 22. United States Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Naftopidil Sales Market Share by Country (2020-2031)
Figure 25. Europe Naftopidil Revenue Market Share by Country (2020-2031)
Figure 26. Germany Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Naftopidil Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Naftopidil Revenue Market Share by Region (2020-2031)
Figure 33. China Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Naftopidil Sales Market Share by Country (2020-2031)
Figure 43. Latin America Naftopidil Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Naftopidil Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Naftopidil Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Naftopidil Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Naftopidil by Type (2020-2031)
Figure 53. Global Revenue Market Share of Naftopidil by Type (2020-2031)
Figure 54. Global Naftopidil Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Naftopidil by Application (2020-2031)
Figure 56. Global Revenue Market Share of Naftopidil by Application (2020-2031)
Figure 57. Global Naftopidil Price (US$/Unit) by Application (2020-2031)
Figure 58. Naftopidil Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232